Drug Profile
L 701667
Latest Information Update: 15 Feb 1996
Price :
$50
*
At a glance
- Originator Merck & Co
- Class Antibacterials; Macrolides
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 15 Feb 1996 No-Development-Reported for Bacterial infections in USA (PO)